Swiss multinational pharmaceutical company Novartis says its programmes to promote research among young scientists are starting to bear fruit. Colin Pillai, head of global scientific capabilities at Novartis, said he hoped more private companies would promote and enable high-end scientific research in SA. Pillai is responsible for the Next Generation Scientist programme, which funds the secondment of young scientists to Basel, Switzerland, in the interests of knowledge transfer. The programme, which was launched in 2011, benefits about 20 international master’s, PhD and post-doctoral students from low-and middle-income countries every year. It is jointly run with the University of Basel. Students are selected to participate in the three-month programme, which is hosted at the Novartis campus in Basel, where they collaborate with Novartis experts on projects in their field of study. Pillai said two young scientists working in SA, Madichaba Phuti Chelopo and Mathew Njoroge, both parti...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.